Phase I study of neoadjuvant 5-fluorouracil (5FU) chemoradiation (CRT) and trametinib in patients with locally advanced rectal cancers (LARC)

被引：1
|
作者：
Wu, Christina Sing-Ying
Williams, Terence M.
Wei, Lai
Umar, Hamida
Mikhail, Sameh
Ciombor, Kristen Keon
Noonan, Anne M.
Roychowdhury, Sameek
El-Dika, Samer S.
Krishna, Somashekar
Upchurch, Bennie
McCarthy, Sean T.
Arnold, Mark
Harzman, Alan
Abdel-Misih, Sherif
Cirocco, William
Traugott, Amber
Bekaii-Saab, Tanios S.
Wuthrick, Evan John
机构：
[1] Emory Univ, Atlanta, GA USA
[2] Ohio State Univ, James Canc Hosp, Comprehens Canc Ctr, Solove Res Inst, Columbus, OH USA
[3] Ohio State Univ, Arthur G James Canc Hosp, Comprehens Canc Ctr, Columbus, OH USA
[4] Ohio State Univ, Columbus, OH USA
[5] Mayo Clin, Scottsdale, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.685
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
685
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase I study of trametinib with neoadjuvant chemoradiation (CRT) in patients with locally advanced rectal cancers (LARC).
    Wu, Christina Sing-Ying
    Williams, Terence Marques
    Wei, Lai
    Umar, Hamida
    Mikhail, Sameh
    Ciombor, Kristen Keon
    Chan, Emily
    Noonan, Anne M.
    Roychowdhury, Sameek
    El-Dika, Samer S.
    Krishna, Somashekar
    McCarthy, Sean T.
    Arnold, Mark
    Harzman, Alan
    Abdel-Misih, Sherif
    Cirocco, William
    Traugott, Amber
    Bekaii-Saab, Tanios S.
    Wuthrick, Evan John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Phase I study of trametinib and neoadjuvant chemoradiation (CRT) in patients with locally advanced rectal cancers (LARC) that harbor KRAS, BRAF, or NRAS mutations
    Wu, Christina Sing-Ying
    Williams, Terence Marques
    Wei, Lai
    Umar, Hamida
    Savysan, Arsen
    Mikhail, Sameh
    Ciombor, Kristen Keon
    Noonan, Anne M.
    Roychowdhury, Sameek
    El-Dika, Samer S.
    Krishna, Somashekar
    Upchurch, Bennie
    Arnold, Mark
    Harzman, Alan
    Abdel-Misih, Sherif
    Cirocco, William
    Bekaii-Saab, Tanios S.
    Wuthrick, Evan John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] A phase I study of oxaliplatin (OXA), 5-fluorouracil (5FU) and concomitant preoperative irradiation in patients with locally advanced rectal cancer.
    Balart, J
    Marcuello, E
    Garriga, J
    Pernas, J
    Sancho, F
    González, D
    Pétriz, L
    Llaurado, J
    Martínez, A
    Guallar, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 304S - 304S
  • [4] Phase Ib study of neoadjuvant chemoradiation (CRT) with midostaurin, 5-fluorouracil (5-FU) and radiation (XRT) for locally advanced rectal cancer: Sensitization of RAS mutant tumors
    Hong, Theodore S.
    Wo, Jennifer Yon-Li
    Ryan, David P.
    Zheng, Hui
    Borger, Darrell R.
    Kwak, Eunice Lee
    Allen, Jill N.
    Berger, David L.
    Rattner, David W.
    Cusack, James C.
    Gemma, Angelo J.
    Mamon, Harvey J.
    Eyler, Christine E.
    Shellito, Paul C.
    Zhu, Andrew X.
    Goyalx, Lipika
    Goyal, Lipika
    Clark, Jeffrey W.
    Willers, Henning
    Haigis, Kevin M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Phase 1 Study of Trametinib and Neoadjuvant Chemoradiation (CRT) in Locally Advanced Rectal Cancer (LARC) with KRAS, BRAF, or NRAS Mutations
    Wuthrick, E. J.
    Williams, T. M.
    Wei, L.
    Umar, H.
    Savysan, A.
    Mikhail, S.
    Ciombor, K.
    Noonan, A.
    Roychowdhury, S.
    El-Dika, S.
    Krishna, S.
    Upchurch, B.
    Arnold, M.
    Harzman, A.
    Abdel-Misih, S.
    Cirocco, W.
    Bekaii-Saab, T.
    Wu, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S107 - S108
  • [6] Preoperative radiotherapy and concomitant Tomudex plus folinic acid+5-fluorouracil (5FU) for locally advanced rectal cancer (LARC): A phase I study
    Guida, C
    Ravo, V
    Avallone, A
    Delrio, P
    Marone, P
    Parisi, V
    Comella, G
    Morrica, B
    [J]. TUMORI, 2001, 87 (04) : S111 - S112
  • [7] A unicentric phase II study of oxaliplatin (OXA), 5-fluorouracil (5FU) and concomitant preoperative irradiation in patients with locally advanced rectal cancer
    Marcuello, Eugenio
    Nadal, R.
    Capdevila, J.
    Garriga, J.
    Petriz, L.
    Sancho, F. J.
    Pernas, J. A.
    Gonzalez Juan, D.
    Targarona, E.
    Diez, O.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 283 - 283
  • [8] Phase I Trial of Trametinib with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer
    Wu, Christina
    Williams, Terence M.
    Robb, Ryan
    Webb, Amy
    Wei, Lai
    Chen, Wei
    Mikhail, Sameh
    Ciombor, Kristen K.
    Cardin, Dana B.
    Timmers, Cynthia
    Krishna, Somashekar G.
    Arnold, Mark
    Harzman, Alan
    Abdel-Misih, Sherif
    Roychowdhury, Sameek
    Bekaii-Saab, Tanios
    Wuthrick, Evan
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (13) : 3117 - 3125
  • [9] Capecitabine and oxaliplatin versus 5-fluorouracil in the neoadjuvant chemoradiation for patients with locally advanced rectal carcinoma: A comparative study
    Amal, Ibrahim
    Hossam, Abdelhady
    Ahmad, Soliman
    Marwa, Khalaf
    Dalia, Osama
    Khalid, Rezk
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [10] Combined radiotherapy, 5-Fluorouracil (5FU) continuous infusion and weekly Oxaliplatin in advanced rectal cancer: Phase I study
    Francois, Eric D.
    Ychou, Marc
    Ducreux, Michel
    Bertheault-Cvitkovic, Frederique
    Giovannini, Marc
    Conroy, Thierry
    Lemansk, Claire
    Thomas, Oliver
    Mari, Veronique
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 96 - 97
12345